# Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis

> **NCT01135199** · PHASE2 · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Pulmonary Fibrosis

## Interventions

- **DRUG:** pomalidomide (CC-4047

## Key facts

- **NCT ID:** NCT01135199
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** FDA did not accept sponsor's animal toxicology data to support proposed dosing.
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01135199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01135199, "Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01135199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*